We are investigating possible breaches of fiduciary duty and violations of the federal securities laws by the Board of Directors and senior officers of Global Payments Inc. (NYSE: GPN) (“Global Payments” or the “Company”) and its wholly owned subsidiary, Active Network, for engaging in deceptive business practices to enroll consumers in discount club memberships without customer knowledge or consent and for renewing said memberships in violation of Regulation E of the Electronic Fund Transfer Act.
On October 18, 2022, Global Payments was named a defendant by the Consumer Financial Protection Bureau (“CFPB”) for illegally cramming consumers with membership fees. On this news, the price of Global Payments’ stock fell $1.33 to close at $113.67 on October 18, 2022. Analysts have correspondingly significantly reduced their stock price targets for the Company.
Weiss Law has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients. For more information about the firm, please go to: http://www.weisslaw.co
September 26, 2023
We are investigating possible breaches of fiduciary duty and violations of the federal securities laws by, among others, the Board of Directors and senior officers of Origin Materials, Inc. (NASDAQ: ORGN) (“Origin” or the “Company”), concerning the Company’s business, operations, and prospects surrounding the construction of the Origin 2 commercial plant.
September 14, 2023
Weiss Law announces that on September 13, 2023, they filed a class action lawsuit in the United States District Court for the Southern District of New York (“Court”), captioned Zappia v. Myovant Sciences Ltd. et al. Case 1:23-cv-08097, on behalf of a class (“Class”) of individuals and entities that held common stock of Myovant Sciences, Ltd. (“Myovant”) as of the close of business on January 20, 2023 (“Class Period”), asserting claims under Sections 14(a) and 20(a) of the Securities Exchange Act of 1934, and Securities and Exchange Commission Rule 14a-9, in connection with the acquisition of Myovant Sciences, Ltd. by Sumitovant Biopharma Ltd. for an unfair price.
September 11, 2023
We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Hostess Brands, Inc. (“Hostess” or the “Company”) (NASDAQ: TWNK), in connection with its acquisition by The J. M. Smucker Company (NYSE: SJM) (“Smucker”) via tender offer.